In that analysis, we found that in the PRS.noAPOE, among MCI participants without APOE ε4, the high-PRS group showed a significantly higher conversion to AD than the low-PRS group (p value = 0.031, log-rank test; Table 5a and Fig. 3A). The gene discussed is APOE; the disease is Alzheimer disease.